Prandial Insulin Dosing in Hospitalized Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

March 31, 2013

Conditions
DiabetesAdmitting HospitalNon-critically Ill
Interventions
DRUG

Aspart fixed dose

fixed dose

DRUG

Aspart flexible dose

dose based upon carbohydrate intake and total daily requirements

Trial Locations (1)

43210

The Ohio State University, Columbus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Kathleen Dungan

OTHER